Clinical Attribute Network for Chronic Lymphocytic Leukemia

被引:0
|
作者
Kundu, Abhisek [1 ,2 ]
Ozer, Hatice Gulcin [3 ]
Borlawsky, Tara [1 ,5 ]
Circle, Kristin C. [4 ]
Huang, Kun [1 ,3 ]
Payne, Philip [1 ,3 ,5 ]
机构
[1] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Comp Sci, Columbus, OH 43210 USA
[3] Ohio State Univ, OSUCCC Biomed Informat Shared Resource, Columbus, OH 43210 USA
[4] Mt Carmel Hosp, Columbus, OH USA
[5] Ohio State Univ, Ctr Clin & Translat Sci, Columbus, OH 43210 USA
关键词
D O I
10.1109/BIBM.2009.77
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this paper, we present a study on the relationships between Chronic Lymphocytic Leukemia (CLL) related clinical attributes using network visualization and analysis techniques. This work is the first step of our long-term project to identify novel biomarkers for CLL, working in coordination with the NCI-funded CLL Research Consortium (cll.ucsd.edu). By computing Spearman correlation coefficients for 125 clinical attributes, we established an attribute network for CLL. Using network visualization techniques we identified a core network with peripheral nodes around it. An important observation is that many cytogenetic attributes are in the core network, indicating the connection between karyotypes (e.g., abnormality in Chromosome 17) and other clinical attributes. Since these karyotypes are linked to CLL etiology in many ways, the corresponding clinical attributes may be further selected and tested as markers for disease screening. The correlation analysis results are also consistent with previous studies using a knowledge engineering based approach for establishing relationships between such attributes.
引用
收藏
页码:279 / +
页数:2
相关论文
共 50 条
  • [1] CLINICAL STAGING OF CHRONIC LYMPHOCYTIC LEUKEMIA
    RAI, KR
    SAWITSKY, A
    CRONKITE, EP
    CHANANA, AD
    LEVY, RN
    PASTERNACK, BS
    BLOOD, 1975, 46 (02) : 219 - 234
  • [2] Clinical Risks for Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (03):
  • [3] Clinical challenges in chronic lymphocytic leukemia
    O'Brien, S
    SEMINARS IN HEMATOLOGY, 1998, 35 (03) : 22 - 26
  • [4] Chronic Lymphocytic Leukemia A Clinical Review
    Nabhan, Chadi
    Rosen, Steven T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (21): : 2265 - 2276
  • [5] CLINICAL FEATURES OF CHRONIC LYMPHOCYTIC-LEUKEMIA
    SWEET, DL
    GOLOMB, HM
    ULTMANN, JE
    CLINICS IN HAEMATOLOGY, 1977, 6 (01): : 185 - 202
  • [6] Advances in the Clinical Staging of Chronic Lymphocytic Leukemia
    Rai, Kanti R.
    Jain, Preetesh
    CLINICAL CHEMISTRY, 2011, 57 (12) : 1771 - 1772
  • [7] CLINICAL STAGING OF CHRONIC LYMPHOCYTIC-LEUKEMIA
    CASE, DC
    JOURNAL OF THE MAINE MEDICAL ASSOCIATION, 1977, 68 (09): : 328 - &
  • [8] The clinical safety of ibrutinib in chronic lymphocytic leukemia
    Molica, Stefano
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (10) : 1621 - 1629
  • [9] Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia
    Puckrin, Robert
    Owen, Carolyn
    Peters, Anthea
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 636 - 640
  • [10] THE CLINICAL IMPLICATIONS OF HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND LYMPHOCYTIC LYMPHOSARCOMA
    ULTMANN, JE
    FISH, W
    OSSERMAN, E
    GELLHORN, A
    ANNALS OF INTERNAL MEDICINE, 1959, 51 (03) : 501 - 516